sorafenib mylan 200 mg filmom obalené tablety
mylan ireland limited, Írsko - sorafenib - 44 - cytostatica
weldinin
egis pharmaceuticals plc, maďarsko - sorafenib - 44 - cytostatica
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastické činidlá - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
sorafenib sandoz 400 mg
sandoz pharmaceuticals d.d., slovinsko - sorafenib - 44 - cytostatica
sorafenib pharmagen
pharmagen cz s.r.o., Česká republika - sorafenib - 44 - cytostatica
capecitabine fresenius kabi 150 mg filmom obalené tablety
fresenius kabi oncology plc. - kapecitabín - 44 - cytostatica
capecitabine fair-med 500 mg filmom obalené tablety
fair-med healthcare gmbh, nemecko - kapecitabín - 44 - cytostatica
capecitabine fair-med 150 mg filmom obalené tablety
fair-med healthcare gmbh, nemecko - kapecitabín - 44 - cytostatica
lonsurf
les laboratoires servier - trifluridine, tipiracil hydrochlorid - kolorektálne novotvary - antineoplastické činidlá - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
prokanazol 100 mg
exeltis slovakia s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)